Abstract:
Aim of the study: The present study is trying to identify experimental arguments for a magnesium
role in central pain modulation following an intracerebroventricular (icv) administration.
Materials and methods: Healthy adult male Wistar rats, initially weighing 350- 450 g, were used.The
rats were maintained in polyethylene cages with food and water ad libitum, in a laboratory with controlled ambient temperature (21 ± 2°C) and under a 12h light-dark cycle. Groups of 7 rats were treated
with magnesium (Mg) chloride,600 nmol Mg/ rat in 10 pL of saline. Stoelting stereotaxic equipment was
used for icv administration, in previously ether-anesthetized animals. The controled group received an
equal volume of saline. Hot plate and tail clip test was performed before 15, 30, 45, 60, 75 and 90 minutes
after the administration of substances.
Results: Our results show that intracerebroventricular administration of magnesium chloride has an
analgesic effect for the hot plate and tail clip test. The maximum effect was observed after 75 minutes in
tail clip and 90 minutes in hot plate.
Discussions: While the implication of Mg as a divalent cation has been studied before in relation to
pain modulation, this is the first study to look at its effects on nociception after icv administration. As
magnesium blocks the N-methyl-D-aspartate (NMDA) receptor and its associated ion channels, it can
prevent central sensitization caused by peripheral nociceptive stimulation. However magnesium ion can
block Ca influx and at the same time can noncompetitively antagonize NMDA receptor channels
Conclusions: Magnesium has an antinociceptive effect following icv administration. However, the
slow onset of the analgesic effect observed in our experiments may involve a different mechanism or site
of action than cited in the literature.
